| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 20.445 | 41.489 | 29.280 | 29.443 | 51.796 | 42.700 | 48.532 | 45.202 |
| Total Income - EUR | - | - | 21.751 | 41.501 | 39.677 | 29.470 | 51.816 | 43.345 | 48.933 | 45.203 |
| Total Expenses - EUR | - | - | 30.157 | 52.250 | 38.522 | 37.648 | 61.401 | 55.637 | 59.788 | 60.439 |
| Gross Profit/Loss - EUR | - | - | -8.405 | -10.749 | 1.155 | -8.178 | -9.585 | -12.292 | -10.855 | -15.236 |
| Net Profit/Loss - EUR | - | - | -8.623 | -11.164 | 758 | -8.453 | -10.103 | -12.726 | -11.358 | -15.704 |
| Employees | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Iatrofarm 2 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 10.044 | 7.716 | 5.494 | 3.369 | 1.353 | 324 | 202 | 80 |
| Current Assets | - | - | 12.282 | 12.447 | 11.409 | 11.946 | 13.406 | 7.741 | 10.292 | 10.742 |
| Inventories | - | - | 9.143 | 8.025 | 6.727 | 7.839 | 5.750 | 3.676 | 4.286 | 4.177 |
| Receivables | - | - | 2.218 | 3.743 | 4.209 | 2.891 | 5.385 | 3.370 | 5.639 | 5.307 |
| Cash | - | - | 922 | 678 | 473 | 1.216 | 2.271 | 695 | 367 | 1.258 |
| Shareholders Funds | - | - | -8.579 | -19.586 | -18.448 | -26.552 | -36.066 | -48.904 | -60.114 | -75.481 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 30.905 | 39.769 | 35.351 | 41.866 | 50.826 | 56.968 | 70.607 | 86.304 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Iatrofarm 2 Srl